KAREN WINTERBURN: Open Payments
NPI 1801857552 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 12 payments from 5 companies in 2025. Trend: 2023 $365 · 2024 $464 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| Astellas Pharma US Inc | 3 | $61 |
| Lilly USA, LLC | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| ABBVIE INC. | 1 | $20 |
Products named: Wegovy, Veozah, MYFEMBREE, ZEPBOUND, LILETTA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
